New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
08:58 EDTDDD, CTSH, OMER, DATA, VJET, MRK, XONE, SSYS, RL, COCOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Merck (MRK), up 1.6%... Ralph Lauren (RL), up 7%... Tableau Software (DATA), up 12%... Corinthian Colleges (COCO), up 2%. ALSO HIGHER: Omeros (OMER), up 11% after granted fast track designation to OMS824 by FDA. DOWN AFTER EARNINGS: Allergan (AGN), down xx%... Cognizant (CTSH), down 5%. ALSO LOWER: 3D Systems (DDD), down 15% after lowering FY13 EPS view, guiding FY14 below estimates. Peers Stratasys (SSYS), down 7.5%, ExOne (XONE), down 8%, and Voxeljet (VJET), down 7%, lower as well.
News For DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO From The Last 14 Days
Check below for free stories on DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 4, 2014
15:16 EDTMRKMerck receives accelerated approval of Keytruda
Subscribe for More Information
11:20 EDTDDDStocks with increasing options volume
Stocks with increasing options volume: BP VMW SCTY X GE MBLY VALE DDD
10:39 EDTSSYS, DDD3D Systems downgraded on execution concerns at Pacific Crest
Subscribe for More Information
10:29 EDTSSYS, DDDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:29 EDTDDDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:06 EDTDDDOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PVH Corp. (PVH), up 9%... Verifone (PAY), up 3.8%... Methode Electronics (MEI), up 13%... Bazaarvoice (BV), up 9%. ALSO HIGHER: Bolt Technology (BOLT), up 35.7% after Teledyne (TDY) agrees to acquire the company for $22 per share in cash... Mitek Systems (MITK), up 58% after USAA lawsuit settlement... Tibco Software (TIBX), up 7% after announcing that it is reviewing strategic alternatives... Stereotaxis (STXS), up 22% after receiving FDA clearance for Vdrive with V-Loop system... NewLink (NLNK), up 3.4% after reporting FDA approval for Phase 1 clinical studies of Ebola vaccine. DOWN AFTER EARNINGS: Ciena (CIEN), down 3%... Joy Global (JOY), down 1%... Matrix Service (MTRX), down 11%... Mobileye (MBLY), down 1.3%. ALSO LOWER: Yum! Brands (YUM), down 2.8% after updating third quarter China division same-store sales guidance... 3D Systems (DDD), down 2.9% after downgraded at Pacific Crest... GoPro (GPRO), down 3.5% after downgraded at JPMorgan... Shanda Games (GAME), down 4% after announcing reconstitution of special committee.
09:02 EDTMRKMerck's relebactam granted QIDP, fast track designations by FDA
Merck announced that the U.S. Food and Drug Administration has designated relebactam -- previously known as MK-7655 -- the company’s investigational beta-lactamase inhibitor, as a Qualified Infectious Disease Product with designated Fast Track status. The QIDP and Fast Track designations apply to intravenous use of relebactam for the treatment of complicated urinary tract infections, complicated intra-abdominal infections and hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. Relebactam is an investigational, class A and C, beta-lactamase inhibitor that is being evaluated in combination with imipenem/cilastatin in ongoing Phase 2 clinical trials for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. In preclinical studies, relebactam administered in combination with imipenem/cilastatin demonstrated antibacterial activity against a broad range of Gram-negative and beta-lactam-resistant pathogens. Merck plans to initiate Phase 3 studies with relebactam in combination with imipenem/cilastatin in 2015.
08:06 EDTDATATableau resumed with an Outperform at Pacific Crest
Target $84.
08:03 EDTDDD3D Systems downgraded at Pacific Crest
Subscribe for More Information
07:47 EDTSSYSStratasys initiated with an Overweight at Morgan Stanley
Subscribe for More Information
07:47 EDTDDD3D Systems initiated with an Equal Weight at Morgan Stanley
Subscribe for More Information
07:21 EDTMRKMedidata can obtain major new platform customers, says Stifel
Noting that Medidata (MDSO) partners with Veeva, Stifel believes that a number of Veeva (VEEV) customers could become Medidata platform customers, especially if they already use Medidata for R&D and clinical trial solutions. The firm identifies Merck (MRK), Gilead (GILD), and Teva (TEVA) as companies that may become platform clients for Medidata. Stifel keeps a $55 price target and Buy rating on Medidata.
06:19 EDTDDD3D Systems downgraded to Sector Perform from Outperform at Pacific Crest
September 3, 2014
17:25 EDTMRKMerck management to meet with SunTrust
Subscribe for More Information
11:31 EDTDATATableau to host analyst day
Subscribe for More Information
08:31 EDTDDD3D Systems acquires LayerWise, terms not disclosed
Subscribe for More Information
06:06 EDTSSYSStratasys to host analyst meeting
Subscribe for More Information
September 2, 2014
15:55 EDTDDD3D Systems initiated with a Buy at Fintrust
Subscribe for More Information
08:45 EDTDDD3D Systems partners with Vortex VR
Subscribe for More Information
05:46 EDTSSYSStratasys shares to benefit from second half catalysts, says Piper Jaffray
Piper Jaffray believes second half of 2014 catalysts, including the upcoming Analyst/Investor day, the ramping of new products and consistent execution, should allow shares of Stratasys to continue working higher. Piper reiterates an Overweight rating on the stock with a $145 price target.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use